RNA‐Binding Protein Hnrnpa1 Triggers Daughter Cardiomyocyte Formation by Promoting Cardiomyocyte Dedifferentiation and Cell Cycle Activity in a Post‐Transcriptional Manner
Stimulating cardiomyocyte (CM) dedifferentiation and cell cycle activity (DACCA) is essential for triggering daughter CM formation. In addition to transcriptional processes, RNA-binding proteins (RBPs) are emerging as crucial post-transcriptional players in regulating CM DACCA. However, whether post-transcriptional regulation of CM DACCA by RBPs could effectively trigger daughter CM formation remains unknown. By performing integrated bioinformatic analysis of snRNA-seq data from neonatal and adult hearts, this study identified Hnrnpa1 as a potential RBP regulating CM DACCA. Hnrnpa1 expression decreased significantly during postnatal heart development. With the use of α-MHC-H2B-mCh/CAG-eGFP-anillin transgenic mice, Hnrnpa1 overexpression promoted CM DACCA, thereby triggering daughter CM formation and enhancing cardiac repair after myocardial infarction (MI). In contrast, CRISPR/Cas9 technology is used to generate CM-specific Hnrnpa1 knockout mice. Hnrnpa1 knockout inhibited cardiac regeneration and worsened cardiac function in the neonatal MI model. Nanopore RNA sequencing, RIP assay, IP-MS, MeRIP-qPCR, PAR-CLIP and luciferase reporter experiments showed that Hnrnpa1 induced Mettl3 post-transcriptional splicing to inhibit m6A-dependent Pbx1 and E2F1 degradation, thereby increasing Runx1, Ccne1, Cdk2 and Ccnb2 expression to promote CM DACCA. In conclusion, Hnrnpa1 triggered daughter CM formation by promoting CM DACCA in a post-transcriptional manner, indicating that Hnrnpa1 might serve as a promising target in cardiac repair post-MI.
Authors
- Yifei Ruan
- Wangjun Liao (ORCID: https://orcid.org/0000-0002-1364-8442)
- M. Hesse (ORCID: https://orcid.org/0000-0003-0377-9673)
- Qiqi Chen
- Jianping Bin (ORCID: https://orcid.org/0000-0003-4799-1502)
- Guoquan Wei
- Yü Liu (ORCID: https://orcid.org/0000-0003-2211-3535)
- Guojun Chen
- Yilin Zhou (ORCID: https://orcid.org/0009-0000-4748-8865)
- Yanmei Chen
- Yijin Chen (ORCID: https://orcid.org/0000-0001-8794-6584)
- Hao Zheng (ORCID: https://orcid.org/0009-0000-6483-8433)
- Ming Jin (ORCID: https://orcid.org/0000-0003-0414-4506)
- Xiang He (ORCID: https://orcid.org/0000-0002-3893-9537)
- Chuling Li (ORCID: https://orcid.org/0000-0002-1597-6626)
- Senlin Huang
- Yulin Liao
- Haoxiang Huang (ORCID: https://orcid.org/0009-0007-3354-4425)
Institutions
- University of Bonn (DE)
- Key Laboratory of Guangdong Province (CN)
- Nanfang Hospital (CN)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN)
- Life & Brain (Germany) (DE)
- Southern Medical University (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1002/advs.202402371
- Citations
- 6
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Natural Science Foundation of China
- Rheinische Friedrich-Wilhelms-Universität Bonn
- Southern Medical University
- Nanfang Hospital
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory
- Basic and Applied Basic Research Foundation of Guangdong Province